Since 2008, the FDA has approved TMS therapy for the treatment of patients with major depression who failed to improve from antidepressant medication.
Many patients have reported significant benefits, demonstrating the effectiveness and safety of TMS1:
- 1 in 2 patients improved significantly
- 1 in 3 patients were free of depression symptoms
- Durable symptom relief over 12 months
In a randomized controlled trial funded by the National Institute of Mental Health, patients who underwent TMS treatment were 4x more likely to achieve remission from major depression compared to those who received inactive treatment2:
References:
1. Carpenter LL, et al. (2012) Depress Anxiety, 29(7):587-596. 2. Demitrack MA, Thase ME. (2009) Psychopharmacol Bull, 42(2):5-38